Assembly Biosciences, Inc. · NASDAQ:ASMB
Armistice Capital, LLC reported a 9.99% stake in Assembly Biosciences, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Armistice Capital, LLC reported a 9.99% stake in Assembly Biosciences, Inc., 289,876 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 289,876
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 289,876 |
| Steven Boyd | 9.99% | 289,876 |
Source
Related
- Assembly Biosciences, Inc.
- Armistice Capital, LLC
- Assembly Biosciences, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 4, 2026
- Form 4 · Bjorkquist Jeanette M · Jun 18, 2026
- Form 4 · Gaggar Anuj · Jun 5, 2026